Active Immunotherapy to Prevent Alzheimer Disease-A DNA Amyloid beta 1-42 Trimer Vaccine

摘要

This Viewpoint argues that there is a possibility of finding a path forward in Alzheimer disease prevention with the DNA amyloid beta 1-42 timer vaccine that warrants its evaluation in a clinical trial.